Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
IPO
Alerts
(4)
About
Gland Pharma Ltd.
NSE: GLAND
|
BSE: 543245
|
ISIN: INE068V01023
|
Industry: Pharmaceuticals
Margin Growth
52 week high
Insider Trades
|
Mid-range Performer
2331.0000
109.20
(
4.91
%)
NSE
May 21, 2026
15:52 PM
New 52W High today
Volume:
1.0M
High vol.+gain this week
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Gland Pharma Ltd.
04 Nov 2025
Margin Growth
52 week high
Insider Trades
2331.00
4.91%
Result Update:Gland Pharma
Hold:
Gland Pharma Ltd.
by
Axis Direct
Target: 2170 | Target met
Target
Axis Direct
We revise our rating from HOLD to BUY
Gland Pharma has gained
26.40%
in the last 1 Week
More from Gland Pharma Ltd.
Recommended
Stocks that saw institutions raise their stakes over the past quarter
The Baseline |
21 May 2026, 05:31PM
Market closes flat, dragged by losses in IT and FMCG stocks
Trendlyne Marketwatch |
21 May 2026, 03:57PM
Gland Pharma IPO: A Chinese-owned pharmaceutical company hits the IPO market
|
12 Nov 2020